Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250638 · ClinicalTrials.gov registry record
Longitudinal Pancreatic Cancer Study
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 140
- Enrollment target
NCT02250638 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 140 participants.
The verdict
NCT02250638 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
To obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of pancreatic cancer.
Interventions
- OTHER CA 19-9 Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2014-05 |
| Est. Completion | 2021-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02250638
The ClinicalTrials.gov registry entry for NCT02250638 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CA 19-9 Assay is the first listed.
NCT02250638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02250638 about?
NCT02250638 is a clinical study titled "Longitudinal Pancreatic Cancer Study". To obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of pancreatic cancer.
What is the current status of trial NCT02250638?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2014-05. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT02250638?
The interventions under investigation include: CA 19-9 Assay (OTHER).
Who is sponsoring clinical trial NCT02250638?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.